David E. Spaner
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
BRCA1 deficiency induces NFκB-dependent type-I interferon signaling in fallopian tube epithelial cells.
Journal: Neoplasia (New York, N.Y.)
Published: November 28, 2025
High-content imaging of primary chronic lymphocytic leukemia cells predicts patient cohorts with distinct cellular drug responses.
Journal: iScience
Published: June 12, 2025
Effect of Statins in the Watch and Wait Phase of Chronic Lymphocytic Leukemia.
Journal: Cancer medicine
Published: October 28, 2024
Effect of statins on IL-10 signaling and production by chronic lymphocytic leukemia cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 28, 2024
IL-1 receptor antagonism reveals a yin-yang relationship between NFκB and interferon signaling in chronic lymphocytic leukemia.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 09, 2024
ISGylation enhances dsRNA-induced interferon response and NFκB signaling in fallopian tube epithelial cells.
Journal: The Journal of biological chemistry
Published: February 22, 2024
Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo.
Journal: Frontiers in oncology
Published: September 13, 2022
Enhanced IFN Sensing by Aggressive Chronic Lymphocytic Leukemia Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 14, 2022
O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers.
Journal: Frontiers in immunology
Published: September 14, 2021
Effect of Ibrutinib on the IFN Response of Chronic Lymphocytic Leukemia Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 28, 2020
PPARγ inhibits breast cancer progression by upregulating PTPRF expression.
Journal: European review for medical and pharmacological sciences
Published: December 05, 2019
Last Updated: 09/26/2026